Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Immunovant Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arbutus Biopharma Corporation May 22, 202495.0%
-
Arbutus Biopharma Corporation May 24, 202395.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Roivant Sciences Ltd. | Shares withheld for tax | +40,309 | $36.57 | $1,474,100 |
| Jun 30, 2026 | Roivant Sciences Ltd. | Shares withheld for tax | −40,310 | $35.39 | $1,426,571 |
| Apr 7, 2026 | Immunovant Inc. | Grant or award | +174,189 | — | — |
| Mar 31, 2026 | Roivant Sciences Ltd. | Shares withheld for tax | −160,035 | $27.70 | $4,432,970 |
| Feb 23, 2026 | Roivant Sciences Ltd. | Option exercise | +587,390 | $3.85 | $2,261,452 |
| Feb 23, 2026 | Roivant Sciences Ltd. | Open-market sale | −587,390 | $27.51 | $16,159,099 |
| Feb 20, 2026 | Roivant Sciences Ltd. | Option exercise | +1,012,610 | $3.85 | $3,898,549 |
| Feb 20, 2026 | Roivant Sciences Ltd. | Open-market sale | −1,012,610 | $27.15 | $27,492,362 |
| Feb 19, 2026 | Roivant Sciences Ltd. | Option exercise | +1,400,000 | $3.85 | $5,390,000 |
| Feb 19, 2026 | Roivant Sciences Ltd. | Open-market sale | −1,400,000 | $27.42 | $38,388,000 |
| Dec 24, 2025 | Roivant Sciences Ltd. | Other | −64,891 | $22.47 | $1,458,101 |
| Dec 24, 2025 | Roivant Sciences Ltd. | Gift | −110,489 | — | — |
| Dec 23, 2025 | Roivant Sciences Ltd. | Grant or award | +175,380 | $22.45 | $3,937,281 |
| Jul 30, 2025 | Roivant Sciences Ltd. | Grant or award | +1,836,547 | — | — |
| Jul 30, 2025 | Roivant Sciences Ltd. | Grant or award | +11,900,000 | — | — |
Questions about Frank Torti
What boards is Frank Torti on?
Frank Torti sits on the boards of Arbutus Biopharma Corporation and Immunovant Inc.
How long has Frank Torti served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.